The global prevalence of latent tuberculosis: a systematic review and meta-analysis

Cited by (547)

Items 101–200 of 547

1. Challenges in the management of inflammatory bowel disease in sub-Saharan Africa
   Gillian Watermeyer, Yaw Asante Awuku, Ernst Fredericks, David Epstein, Mashiko Setshedi, Smita Devani, Wisdom Mudombi, Chris Kassianides, Leolin Katsidzira · 2022 · The Lancet. Gastroenterology & hepatology
2. Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review
   André Lucas Ribeiro, Larissa Martinelli Dullius, Natália Sarzi Sartori, Andre Azeredo-da-Silva, Charles Lubianca Kohem, Laura C. Coates, Odirlei André Monticielo, Penélope Esther Palominos · 2023 · Clinical Therapeutics
3. Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population
   Christianne Bourlon, Rocío Camacho-Hernández, Oscar Manuel Fierro-Angulo, Aldo A. Acosta‐Medina, Maria Teresa Bourlon, María Dolores Niembro-Ortega, María Fernanda González-Lara, José Sifuentes‐Osornio, Alfredo Ponce‐de‐León · 2020 · Transplantation and Cellular Therapy
4. Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology
   Afsal Kolloli, Ranjeet Kumar, Pooja Singh, Anshika Narang, Gilla Kaplan, Alex Sigal, Selvakumar Subbian · 2021 · Communications Biology
5. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis — end of the road?
   Mwaba, Peter, Chakaya, Jeremiah Muhwa, Petersen, Eskild, Wejse, Christian, Zumla, Alimuddin, Kapata, Nathan · 2020 · International Journal of Infectious Diseases
6. Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity
   Allan H. Pang, Keith D. Green, Nishad Thamban Chandrika, Atefeh Garzan, Ankita Punetha, Selina Y. L. Holbrook, Melisa J. Willby, James E. Posey, Oleg V. Tsodikov, Sylvie Garneau‐Tsodikova · 2022 · European Journal of Medicinal Chemistry
7. A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis
   Zaynab Mousavian, Elin Folkesson, Gabrielle Fröberg, Fariba Foroogh, Margarida Correia‐Neves, Judith Bruchfeld, Gunilla Källenius, Christopher Sundling · 2022 · iScience
8. Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland
   Marius Zeeb, Burcu Tepekule, Katharina Kusejko, Claudine Reiber, Marisa Kälin, Lena Bartl, Julia Notter, Hansjakob Furrer, Matthias Hoffmann, Hans Hellmuth Hirsch et al. · 2023 · Clinical Infectious Diseases
9. Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
   Sonali Kochhar, Dráurio Barreira, Pauline Beattie, Marco Cavaleri, Alejandro Cravioto, Mike Watson Frick, Ann M. Ginsberg, Ian Hudson, David C. Kaslow, Sherry L. Kurtz et al. · 2022 · Vaccine
10. The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic
    Sylvia Annabel Dass, Venugopal Balakrishnan, Norsyahida Arifin, Crystale Siew Ying Lim, Fazlina Nordin, Gee Jun Tye · 2022 · Frontiers in Immunology
11. Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid—Preventive therapies for people living with HIV
    Pia Müller, Luís Velez Lapão · 2022 · PLoS ONE
12. Helminth species-specific effects on IFN-γ producing T cells during active and latent tuberculosis
    Amare Kiflie, Gezahegn Bewket, Fitsumbrhan Tajebe, Ebba Abate, Thomas Schön, Robert Blomgran · 2023 · PLoS neglected tropical diseases
13. Advances in the Diagnosis of Latent Tuberculosis Infection
    H R Zhang, Weiwei Guan, Jikun Zhou · 2025 · Infection and Drug Resistance
14. Tuberculosis Diagnosis and Management: Recent Advances
    Arti Shrivas, Sarman Singh · 2025 · Journal of Global Infectious Diseases
15. Mycobacterium tuberculosis-specific CD4 T-cell scoring discriminates tuberculosis infection from disease
    Andrej Mantei, Tim Meyer, Mariana Schürmann, Christiane Beßler, Harald Bias, David Krieger, Torsten Thomas Bauer, Petra Bächer, Johannes Helmuth, Hans‐Dieter Volk et al. · 2022 · European Respiratory Journal
16. Impact of diabetes mellitus on immunity to latent tuberculosis infection
    Nathella Pavan Kumar, Subash Babu · 2023 · Frontiers in Clinical Diabetes and Healthcare
17. Role of latent tuberculosis infection on elevated risk of cardiovascular disease: a population-based cohort study of immigrants in British Columbia, Canada, 1985–2019
    Md. Belal Hossain, James Cameron Johnston, Victoria J. Cook, Mohsen Sadatsafavi, Hubert Wong, Kamila Romanowski, Mohammad Ehsanul Karim · 2023 · Epidemiology and Infection
18. A smooth tubercle bacillus from Ethiopia phylogenetically close to the Mycobacterium tuberculosis complex
    Bazezew Yenew, Arash Ghodousi, Getu Diriba, Ephrem Tesfaye, Andrea Maurizio Cabibbe, Misikir Amare, Shewki Moga, Ayinalem Alemu, Biniyam Dagne, Waganeh Sinshaw et al. · 2023 · Nature Communications
19. A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis
    Zhidong Hu, Jing-xian Xia, Juan Wu, Huimin Zhao, Ping Ji, Ling Gu, Wenfei Gu, Zhenyan Chen, Jinchuan Xu, Xuejiao Huang et al. · 2024 · Emerging Microbes & Infections
20. Situation Analysis of Early Implementation of Programmatic Management of Tuberculosis Preventive Treatment among Household Contacts of Pulmonary TB Patients in Delhi, India
    Yasir Alvi, Sairu Philip, Tanu Anand, Palanivel Chinnakali, Farzana Islam, Neeta Singla, Pruthu Thekkur, Ashwani K. Khanna, B.K. Vashishat · 2024 · Tropical Medicine and Infectious Disease
21. Bacillus Calmette-Guérin vaccination induces a trained innate immunity phenotype in adults over 50 years of age: A randomized trial in Guinea-Bissau
    M. Berendsen, Pauli Bles, Louise Charlotte Johanna de Bree, Kristoffer Jarlov Jensen, Clara Clipet Jensen, Christian Morberg Wejse, Delfim Vicente Mendes, Mihai Gheorghe Netea, Christine Stabell Benn · 2024 · Vaccine
22. Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis
    Jennie Chen, Ashley Hubbard, Laurie Bagley, Rita Shiau, Robert J. Wong, Amit S. Chitnis · 2021 · Digestive Diseases and Sciences
23. The prevalence of latent tuberculosis infection in patients with chronic kidney disease: A systematic review and meta-analysis
    Ayinalem Alemu, Zebenay Workneh Bitew, Getu Diriba, Getachew Seid, Shewki Moga, Saro Abdella, Emebet Gashu, Kirubel Eshetu, Getachew Tollera, Mesay Hailu Dangisso et al. · 2023 · Heliyon
24. Screening for Latent Tuberculosis in Migrants - Status Quo and Future Challenges.
    Eskild Petersen, S. Al-Abri, Amina al Jardani, Z. Memish, Eleni Aklillu, F. Ntoumi, P. Mwaba, C. Wejse, A. Zumla, Fatma Al-Yaquobi · 2024 · International Journal of Infectious Diseases
25. Assessing the risk of TB progression: Advances in blood-based biomarker research
    Zhaodong Li, Yunlong Hu, Fa Zou, Wei Gao, SiWan Feng, Guanghuan Chen, Jing Yang, Wenfei Wang, Chenyan Shi, Yi Cai et al. · 2024 · Microbiological Research
26. Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies
    Ondrej Kovar, Martin Kufa, Vladimír Finger, Ondřej Soukup, Martin Krátký, Carilyn Torruellas, Jaroslav Roh, Jan Korábečný · 2025 · Journal of Medicinal Chemistry
27. QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients
    Evangeline Ann Daniel, Kannan Thiruvengadam, Anuradha Rajamanickam, Chandrasekaran Padmapriyadarsini, Sathyamurthi Pattabiraman, Brindha Bhanu, Amsaveni Sivaprakasam, Mandar Paradkar, Vandana Kulkarni, Rajesh Prabhakar Karyakarte et al. · 2022 · Clinical Infectious Diseases
28. Cytokine Responses during Mycobacterium tuberculosis H37Rv and Ascaris lumbricoides Costimulation Using Human THP-1 and Jurkat Cells, and a Pilot Human Tuberculosis and Helminth Coinfection Study
    Khethiwe N. Bhengu, Ravesh Singh, Pragalathan Naidoo, Miranda N. Mpaka-Mbatha, Nomzamo Nembe-Mafa, Zilungile L. Mkhize‐Kwitshana · 2023 · Microorganisms
29. Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence
    Alberto Matteelli, Gavin Churchyard, Daniela María Cirillo, Saskia den Boon, Dennis Falzon, Yohhei Hamada, Rein M G J Houben, Avinash Kanchar, Afrânio Lineu Kritski, Blessina Kumar et al. · 2024 · PLOS Global Public Health
30. Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experience
    Yong‐Pyo Lee, Byeong‐Ho Jeong, Yeonghee Eun, Cheol‐In Kang, Sehhoon Park, Hyun Ae Jung, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park et al. · 2021 · European Journal of Cancer
31. Latent Tuberculosis Infection Diagnosis among Household Contacts in a High Tuberculosis-Burden Area: a Comparison between Transcript Signature and Interferon Gamma Release Assay
    Sheetal Kaul, Vivek Nair, Shweta Birla, Shikha Dhawan, Sumit Rathore, Vishal Khanna, Sheelu Lohiya, Shakir Ali, Shamim Mannan, Kiran Rade et al. · 2022 · Microbiology Spectrum
32. Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis
    Peter D. Craggs, Luiz Pedro S. de Carvalho · 2022 · Current Opinion in Microbiology
33. Lymphocyte Non-Specific Function Detection Facilitating the Stratification of Mycobacterium tuberculosis Infection
    Ying Luo, Ying Xue, Yimin Cai, Qun Lin, Guoxing Tang, Huijuan Song, Wei Liu, Liyan Mao, Yuan Xu, Yu Zhou et al. · 2021 · Frontiers in Immunology
34. Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection
    Ying Luo, Ying Xue, Guoxing Tang, Qun Lin, Huijuan Song, Wei Liu, Botao Yin, Jin Huang, Wei Wei, Liyan Mao et al. · 2021 · Frontiers in Immunology
35. Improving screening and management of latent tuberculosis infection: development and evaluation of latent tuberculosis infection primary care model
    Marina Kunin, Mark Timlin, Christopher N. Lemoh, David A. Sheffield, Alana Russo, Shegofa Hazara, Jacqueline McBride · 2022 · BMC Infectious Diseases
36. Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review
    Sipang Pangprasertkul, Nida Buawangpong, Kanokporn Pinyopornpanish, Wichuda Jiraporncharoen, Chaisiri Angkurawaranon · 2025 · BMC Infectious Diseases
37. Host Immune Response to Mycobacterium tuberculosis Infection: Implications for Vaccine Development
    Qianfei Liu, Shuping Que, Yixuan Qiu, Mingxing Tang, Shaohua Liu, Guanteng Yang, Yuxiang Wang, Ang Deng, Xiaojiang Hu, X L Lian et al. · 2025 · Journal of Inflammation Research
38. First evaluation of the performance of portable IGRA, QIAreach® QuantiFERON®-TB in intermediate TB incidence setting
    Z. A. Aziz, N. M. Noordin, Wan Mazlina Wan Mohd, M. Kasim · 2023 · PLoS ONE
39. Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease
    Matthias J. Neuböck, Gunar Günther, Aleksandra M. Barac, Jesper Rømhild Davidsen, Christian Borbjerg Laursen, Ritesh Agarwal, Inderpaul Singh Sehgal, Christoph G. Lange, Helmut J.F. Salzer, for CPAnet · 2024 · Seminars in Respiratory and Critical Care Medicine
40. A scoring system developed from a nomogram to differentiate active pulmonary tuberculosis from inactive pulmonary tuberculosis
    Qi Yu, Jisong Yan, Shan Tian, Wujin Weng, Hong Luo, Gang Wei, Gangyu Long, Jun Ma, Fengyun Gong, Xiaorong Wang · 2022 · Frontiers in Cellular and Infection Microbiology
41. High accuracy of recombinant fusion protein early secretory antigenic target protein 6‐culture filtrate protein 10 skin test for the detection of tuberculosis infection: a phase III, multi‐centered, double‐blind, hospital‐based, randomized controlled trial
    Lu Xia, Miao Xu, Feng Li, Tao Li, Heng Yang, Weihua Wang, Qi Wu, Youlun Li, Xiaohong Chen, Qinfang Ou et al. · 2022 · International Journal of Infectious Diseases
42. Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda
    Rachel Lim, Fred Collins Semitala, Elly Atuhumuza, Laban Sabiti, Jane Namakula-Katende, Winnie R. Muyindike, Moses Robert Kamya, David W. Dowdy, Adithya Cattamanchi · 2021 · PLoS ONE
43. Global reporting on tuberculosis preventive treatment among contacts
    Dennis Falzon, Saskia den Boon, Avinash Kanchar, Matteo Zignol E, Giovanni Battista Migliori, Tereza Kasaeva · 2022 · European Respiratory Journal
44. Association of Cytokine Gene Polymorphisms and Their Impact on Active and Latent Tuberculosis in Brazil’s Amazon Region
    Ednelza da Silva Graça Amoras, Thais Gouvêa de Morais, Rafaella do Nascimento Ferreira, Samara Tatielle Monteiro Gomes, Francisca Dayse Martins de Sousa, Iury de Paula Souza, Ricardo Ishak, Antônio Carlos Rosário Vallinoto, Maria Alice Freitas Queiroz · 2023 · Biomolecules
45. Gut microbiota composition and diversity before, during, and two months after rifamycin-based tuberculosis preventive therapy
    Marie Nancy Séraphin, Julia Bellot, Emily M. Klann, Maria Ukhanova, Florence G. Saulsberry, Charles A. Peloquin, Volker Mai · 2023 · Scientific Reports
46. The significance of persisters in tuberculosis drug discovery: Exploring the potential of targeting the glyoxylate shunt pathway
    Anjali Negi, Rashmi Sharma · 2023 · European Journal of Medicinal Chemistry
47. Influence of tuberculosis knowledge on acceptance of preventive treatment and the moderating role of tuberculosis stigma among China’s general population: cross-sectional analysis
    Nan Wang, Lin Wu, Zhaoyue Liu, Junping Liu, Xinru Liu, Yajie Feng, Huanyu Zhang, Xinle Yin, Yaping Liu, Yue Zhou et al. · 2024 · BMC Public Health
48. The Trend of Tuberculosis Case Notification Rates from 1995 to 2022 by Country Income and World Health Organization Region
    Kobto G. Koura, Anthony David Harries · 2024 · Tropical Medicine and Infectious Disease
49. Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis
    Robert J. Wong, Ashley Hubbard, Laurie Bagley, Rita Shiau, Amit S. Chitnis · 2021 · Journal of Clinical Gastroenterology
50. Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis
    José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Ellis Daniela Maldonado-Díaz, Graciela Cárdenas, Luis Alejandro Fernández-López, José Luis Soto‐Hernández, Marcela Verónica Muñoz-Torrico, Gustavo Ramírez-Martínez, Alfredo Cruz‐Lagunas, Armando Vega López et al. · 2021 · Journal of Immunology Research
51. Serological and cellular inflammatory signatures in end‐stage kidney disease and latent tuberculosis
    Milla R. McLean, Kathleen M. Wragg, Ester López, Sandra A. Koesters Kiazyk, Terry Blake Ball, Joe Bueti, Stephen John Kent, Jennifer A. Juno, Amy W. Chung · 2021 · Clinical & Translational Immunology
52. Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: a systematic review of randomised controlled clinical trials
    Lydia Wilson, Lara Gracie, Farah Kidy, G. Neil Thomas, Krishnarajah Nirantharakumar, Sheila Greenfield, Semira Manaseki‐Holland, Derek J. Ward, Tiffany E Gooden · 2023 · BMC Infectious Diseases
53. Cytokine/chemokine profiles in people with recent infection by Mycobacterium tuberculosis
    Mariana Herrera, Yoav Keynan, Lucelly López, Diana Marín, Lázaro Agustín Vélez, Paul J. McLaren, Zulma Vanessa Rueda · 2023 · Frontiers in Immunology
54. Helminth Antigen Exposure Enhances Early Immune Control of Mycobacterium tuberculosis in Monocytes and Macrophages
    Shambhuprasad Kotresh Togarsimalemath, Giggil Pushpamithran, Thomas Schön, Olle I. Stendahl, Robert Blomgran · 2020 · Journal of Innate Immunity
55. Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance
    Monika Szturmowicz, Beata Broniarek-Samson, Urszula Anna Demkow · 2021 · Journal of Occupational Medicine and Toxicology
56. Tuberculosis Disability Adjusted Life Years, Colombia 2010–2018
    Laura Inés Plata‐Casas, Óscar Alexander Gutiérrez Lesmes, Favio Cala Vitery · 2022 · Tropical Medicine and Infectious Disease
57. Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and Lactation
    Adeniyi Olagunju, Jyoti S. Mathad, Ahizechukwu Chigoziem Eke, Sinead Delaney-Moretlwe, Shahin Lockman · 2022 · Clinical Infectious Diseases
58. A costing framework to compare tuberculosis infection tests
    Amanda N. Brumwell, Jade Tso, Viswanath Pingali, Ana Karina Millones, Judith Jiménez, Roger I. Calderon, Nadia N. Barreda, Leonid W. Lecca, Tom Nicholson, Meredith B. Brooks · 2023 · BMJ Global Health
59. Comparative diagnostic accuracy of ChatGPT-4 and machine learning in differentiating spinal tuberculosis and spinal tumors
    Xiaojiang Hu, Dongcheng Xu, Hongqi Zhang, Mingxing Tang, Qile Gao · 2025 · The Spine Journal
60. Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
    Mayara Lisboa Bastos, Olivia Oxlade, Jonathon R. Campbell, Eduardo Faerstein, Dick Menzies, Anete Trajman · 2022 · The Lancet Regional Health - Americas
61. SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression
    Laura Cioetto Mazzabò, Francesca Boldrin, Claire Beauvineau, Martin Tobias Speth, Alberto Marina, Amine Namouchi, Greta Segafreddo, Mena Cimino, Sandrine Favre-Rochex, Seetha V. Balasingham et al. · 2022 · Nucleic Acids Research
62. Biodistribution, pharmacokinetics and toxicity evaluation of mannosylated gelatin nanoparticles of linezolid for anti-tubercular therapy
    Kiran Dayaram Patil, Shashikant B. Bagade, Smita Bonde · 2020 · Materials Technology
63. Structure–activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting Mtb -FtsZ as antitubercular agents
    Krupanandan Haranahalli, Simon Tong, Saerom Kim, Monaf Awwa, Lei Chen, Susan E. Knudson, Richard A. Slayden, Eric Singleton, Riccardo Russo, Nancy D Connell et al. · 2020 · RSC Medicinal Chemistry
64. Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States
    Robert J. Wong, Harvey W. Kaufman, Justin K. Niles, William A. Meyer, Amit S. Chitnis · 2022 · Journal of Public Health Management and Practice
65. 3D host cell and pathogen-based bioassay development for testing anti-tuberculosis (TB) drug response and modeling immunodeficiency
    Shilpaa Mukundan, Rachana Bhatt, John Lucas, Matthew Teryek, Theresa Li-Yun Chang, Selvakumar Subbian, Biju Parekkadan · 2021 · BioMolecular Concepts
66. Tuberculosis in Ukrainian War Refugees and Migrants in the Czech Republic and Slovakia: A Molecular Epidemiological Study
    Matúš Dohál, Věra Dvořáková, Miluše Šperková, Martina Pinková, Arash Ghodousi, Maryam Omrani, Igor Porvazník, Erik Michael Rasmussen, Mária Škereňová, Michaela Krivošová et al. · 2023 · Journal of Epidemiology and Global Health
67. Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?
    Vivekanandhan Aravindhan, Srinivasan Yuvaraj · 2024 · Frontiers in Endocrinology
68. A brief overview of mathematical modeling of the within-host dynamics of Mycobacterium tuberculosis
    Dipanjan Chakraborty, Saikat Batabyal, Vitaly V. Ganusov · 2024 · Frontiers in Applied Mathematics and Statistics
69. Global tuberculosis disease and infection in systemic lupus erythematosus patients: A systematic review and meta-analysis
    Guntur Darmawan, Lie Monica Sherine Liman, Suryo Anggoro Kusumo Wibowo, Laniyati Hamijoyo, Lika Apriani, Nur Atik, Bachti Alisjahbana, Edhyana Sahiratmadja · 2024 · Lupus
70. Clinical Features and Predictors of Treatment Outcome in Patients with Ocular Tuberculosis from the Netherlands and Indonesia: The OculaR TB in Low versus High Endemic Countries (ORTEC) Study
    Ikhwanuliman Putera, Josianne C. ten Berge, Alberta A. H. J. Thiadens, Willem A. Dik, Rupesh V. Agrawal, P. Martin van Hagen, Rina La Distia Nora, Saskia M. Rombach · 2024 · Ocular Immunology and Inflammation
71. The puzzle of the evolutionary natural history of tuberculosis
    Mustapha Fellag, Ahmed Loukil, Michel Drancourt · 2020 · New Microbes and New Infections
72. The association between diabetes status and latent-TB IGRA levels from a cross-sectional study in eastern China
    Cheng Chen, Xinsong Hu, Yan Shao, Honghuan Song, Guoli Li, Wei Lu, Leonardo Martínez, Jianfang Xu, Limei Zhu · 2023 · Frontiers in Cellular and Infection Microbiology
73. Latent Tuberculosis Infection and Associated Risk Factors among People Living with HIV and HIV-Uninfected Individuals in Lithuania
    E. Matulyte, Z. Kancauskiene, Aidas Kausas, J. Urbonienė, V. Lipnickiene, Jelena Kopeykinienė, Tomas Gudaitis, Šarūnas Raudonis, E. Danila, D. Costagliola et al. · 2023 · Pathogens
74. Can immunization with Bacillus Calmette-Guérin be improved for prevention or therapy and elimination of chronic Mycobacterium tuberculosis infection?
    Ángel H. Álvarez, Mario Alberto Flores‐Valdez · 2019 · Expert Review of Vaccines
75. Impact of active tuberculosis on treatment decisions in cancer
    Chandran K. Nair, Manuprasad Avaronnan, Praveen Kumar Shenoy, Vineetha Raghavan, Priya Jayarajan, Parthiban Rudrapathy, Karthickeyan Duraisamy, Satheesan Balasubramanian · 2020 · Current Problems in Cancer
76. Association of Smoking and Drug Abuse with Treatment Failure in Individuals with Tuberculosis: A Case-Control Study
    Homa Serpoosh, Yadollah Hamidi, Payman Eini, Younes Mohammadi · 2020 · Advances in respiratory medicine
77. Tuberculosis in childhood and adolescence: a view from different perspectives
    Tony Tannous Tahan, Betina Mendez Alcântara Gabardo, Andrea M.O. Rossoni · 2020 · Jornal de Pediatria (Versão em Português)
78. Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis
    Asbjørn Langeland Toft, Victor Næstholt Dahl, Armando Sifna, Olusoji Mayowa Ige, Valérie Schwoebel, Mahamadou Bassirou Souleymane, Alberto Piubello, Christian Morberg Wejse · 2022 · International Journal of Infectious Diseases
79. Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection
    Kee Woong Kwon, Tae Gun Kang, Ara Lee, Seung Mo Jin, Yong Taik Lim, Sung Jae Shin, Sang‐Jun Ha · 2023 · Immune Network
80. TB Prevalence Influence on Covid-19 Mortality
    Tareef Fadhil Raham · 2020 · medRxiv
81. Differential Expression of miR-146 and miR-155 in Active and Latent Tuberculosis Infection
    Ebrahim Alijani, Farhad Riazi‐Rad, Asal Katebi, Soheila Ajdary · 2023 · Iranian Journal of Public Health
82. Prevalence of tuberculosis infection among contacts of drug-resistant tuberculosis patients: A systematic review and meta-analysis
    Temesgen Yihunie Akalu, Archie Clements, Eyob Alemayehu Gebreyohannes, Beth Gilmour, Kefyalew Addis Alene · 2024 · Journal of Infection
83. An mRNA vaccine induces antimycobacterial immunity by activating DNA damage repair and autophagy
    Dan Chen, Wei‐Li Huang, Lifang Shen, Junli Zhang, Zhifen Pan, Chen Zhang, Yuting Tang, Ziwei Zhou, Jie Tao, Geyang Luo et al. · 2024 · Molecular Therapy — Nucleic Acids
84. Large gap between attitude and action in tuberculosis preventive treatment among tuberculosis-related healthcare workers in eastern China
    Fei Wang, Yanli Ren, Kui Liu, Ying Peng, Xinyi Chen, Bin Chen, Jianmin Jiang · 2022 · Frontiers in Cellular and Infection Microbiology
85. Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
    Yu Kyung Jun, Seong‐Joon Koh, Dae‐Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im · 2023 · Intestinal Research
86. Global tuberculosis prevention: should we start from the beginning?
    Giovanni Sotgiu, Delia Goletti, Alberto Matteelli · 2019 · European Respiratory Journal
87. HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens
    Noëmi Meier, Manuel Battegay, Tom H. M. Ottenhoff, Hansjakob Furrer, Johannes Nemeth, Nicole Ritz · 2021 · Frontiers in Immunology
88. Design and synthesis of novel 5-alkynyl pyrimidine nucleosides derivatives: Influence of C-6-substituent on antituberculosis activity
    Alexander N. Volov, Nikolai A. Volov, Yana B. Platonova · 2021 · Bioorganic & Medicinal Chemistry Letters
89. Assay design for unambiguous identification and quantification of circulating pathogen-derived peptide biomarkers
    Qingbo Shu, Shan Liu, Tonino Alonzi, Sylvia M. LaCourse, Dhiraj Kumar Singh, Duran Bao, Dalton C. Wamalwa, Li Jiang, Christopher J. Lyon, Grace C. John-Stewart et al. · 2022 · Theranostics
90. A cost-effectiveness evaluation of latent tuberculosis infection screening of a migrant population in Malaysia
    Erin Barker, Joe W. E. Moss, Hayden Holmes, Catherine Bowe, Vinay Suryaprakash, Riccardo Alagna, Vladyslav Nikolayevskyy, Marc Destito, Davide Manissero · 2023 · Scientific Reports
91. Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones
    Rüdiger W. Seidel, Adrian Richter, Richard Goddard, Peter Imming · 2023 · Chemical Communications
92. Deletion of N-acetylmuramyl-L-alanine amidases alters the host immune response to Mycobacterium tuberculosis infection
    Nathan Scott Kieswetter, Mumin Ozturk, Shelby-Sara Jones, Sibusiso Senzani, Melissa Dalcina Chengalroyen, Frank Brombacher, Bavesh Davandra Kana, Reto Guler · 2021 · Virulence
93. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020
    Ioana Mărgineanu, Kieran Rustage, Teymur Noori, Dominik Zenner, Christina Greenaway, Manish Pareek, Onno W. Akkerman, Sally E. Hayward, Jon S Friedland, Delia Goletti et al. · 2022 · Eurosurveillance
94. Tuberculosis preventive treatment in children and adolescents: an observational study of secondary data
    Tony Tannous Tahan, Andrea Maciel de Oliveira Rossoni, Maurício Bedim dos Santos, Juliana Taques Pessoa da Silveira, Simoni Pimenta de Oliveira, Cristina de Oliveira Rodrigues · 2023 · Jornal de Pediatria
95. Integrative and comparative genomic analyses of mammalian macrophage responses to intracellular mycobacterial pathogens
    Thomas Jonathan Hall, Gillian P. McHugo, Michael P. Mullen, James A. Ward, Kate E. Killick, John Arthur Browne, Stephen Vincent Gordon, David Evan MacHugh · 2023 · Tuberculosis
96. Temporal trend in the incidence of tuberculosis-HIV coinfection in Brazil, by macro-region, Federative Unit, sex and age group, 2010-2021
    Lucas Vinícius de Lima, Gabriel Pavinati, Rosana Rosseto de Oliveira, Rodrigo de Macedo Couto, Kleydson Bonfim Andrade Alves, Gabriela Tavares Magnabosco · 2024 · Epidemiologia e Serviços de Saúde
97. Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease
    Karolína Doležalová, Petra Hadlová, Markéta Ibrahimová, Jaroslav Goliáš, Ľuboš Bača, Emília Kopecká, Mariia Sukholytka, Martina Vašáková · 2024 · Tuberculosis
98. Risk factors for latent tuberculosis infection clustering among the elderly: a population-based cross-sectional study in Eastern China
    Zhenguo Zhu, Wei Shen, Jiajun Hu, Meng Jin, Lijie Shi, Yafang Wu, Jianliang Fan · 2025 · BMC Infectious Diseases
99. The burden and predictors of latent tuberculosis infection among immigrants in South Korea: a retrospective cross-sectional study
    Sarah Yu, Dawoon Jeong, Hongjo Choi · 2021 · BMC Infectious Diseases
100. Multicenter Analysis of Attrition from the Pediatric Tuberculosis Infection Care Cascade in Boston
     Jeffrey I. Campbell, Mary Tabatneck, Mingwei Sun, Wei A. He, Nicholas Musinguzi, Bethany Hedt‐Gauthier, Gabriella S Lamb, Kezia Domond, Don A. Goldmann, Vishakha Sabharwal et al. · 2022 · The Journal of Pediatrics